The Berlin Institute of Health at Charité (BIH) is delighted to announce the next international stop of its successful touring exhibition “Berlin – Capital of Women Scientists”, now on display at the Goethe-Institut Lyon. From 17 January to 28 March 2026, visitors can explore the stories of 22…
Prostate cancer is the most common cancer among men in 112 countries worldwide. However, if prostate cancer is detected early enough, the chances of recovery are very high. This requires that the disease be detected early enough using meaningful biomarkers. Dr. Maximilian Lindholz and Dr. Charlie…
The liver plays a central role in the body’s metabolism and immune regulation. Yet, many cellular mechanisms involved in liver diseases remain only partially understood. Researchers from Charité, Si-M – The Simulated Human and the Cincinnati Children’s Hospital Medical Center have now gained crucial…
BALANCE-ET, a research project involving the BIH, examines the quality of life of breast cancer survivors and investigates how relapses and long-term side effects can be better prevented. On February 4, State Secretary Matthias Hauer presented the funding approval during his visit to the National…
Charité – Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH), and Enterprise Singapore (ESG) are continuing their successful international collaboration. In November 2025, the Memorandum of Understanding (MoU) underpinning their joint co-innovation programme was renewed for…
To ensure that people are not only treated when they are ill, but that diseases do not develop in the first place, medicine must systematically incorporate preventive measures. The BIH Biomedical Innovation Academy (BIA) and Charité – Universitätsmedizin Berlin are launching their Advanced Clinician…
BIH Professor Dr. Carsten Tschöpe received special recognition at the “HFA Winter Meeting on Translational Heart Failure Research” in Berlin. He delivered the prestigious Brutsaert Lecture to an international audience—an honor linked to a lifetime achievement award in translational cardiovascular…
BIH professor Kirsten Kübler has been awarded the Claudia von Schilling Prize 2025, worth €10,000, for her publication on tamoxifen-associated uterine cancer.
Oslo Cancer Cluster, in collaboration with the Berlin Center for Gene and Cell Therapies, has published a new whitepaper “Bridging the Gaps: Unlocking the Future of Advanced Therapies in Europe via Novel Alliances.” The whitepaper builds on a expert roundtable hosted at the Nordic Embassies in…
